PubRank

Anjo J P Veerman

Author PubWeight™ 50.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 2004 4.16
2 Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012 2.56
3 Intrathecal vincristine: 3 fatal cases and a review of the literature. J Pediatr Hematol Oncol 2009 2.04
4 The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica 2006 1.83
5 Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol 2013 1.67
6 FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood 2003 1.65
7 The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 2006 1.63
8 Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer 2005 1.57
9 Congenital leukaemia: the Dutch experience and review of the literature. Br J Haematol 2002 1.28
10 Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood 2002 1.27
11 Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer 2009 1.27
12 Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol 2011 1.25
13 The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica 2012 1.18
14 Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 2006 1.13
15 Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. Cancer 2006 1.11
16 Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences. Psychooncology 2010 1.10
17 Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia. Blood 2006 1.05
18 Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia. Clin Pharmacol Ther 2004 0.97
19 Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia. J Clin Oncol 2008 0.96
20 Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. J Int Neuropsychol Soc 2005 0.95
21 Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer 2005 0.94
22 Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leuk Res 2007 0.93
23 Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment. Clin Chim Acta 2005 0.90
24 Long term survivors of childhood cancer: cure and care. The Erice statement. Eur J Cancer 2007 0.90
25 Glucocorticoid resistance in childhood leukaemia: mechanisms and modulation. Br J Haematol 2003 0.90
26 Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). Biochem Pharmacol 2004 0.90
27 Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma. Br J Haematol 2004 0.89
28 Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia. Pediatr Blood Cancer 2008 0.87
29 Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high? Eur J Cancer 2007 0.87
30 The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. Biochem Pharmacol 2003 0.85
31 Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes 2008 0.84
32 High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children. Leuk Lymphoma 2003 0.83
33 Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities. Blood 2002 0.83
34 Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol. J Oncol 2012 0.82
35 CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer 2008 0.82
36 Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions. J Pediatr Oncol Nurs 2009 0.81
37 Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998-2009. Pediatr Blood Cancer 2011 0.80
38 Attitude of health-care providers toward childhood leukemia patients with different socio-economic status. Pediatr Blood Cancer 2008 0.80
39 Cryptococcal meningitis in a child with acute lymphoblastic leukemia. Pediatr Infect Dis J 2003 0.80
40 Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects. Eur J Cancer 2005 0.79
41 Early Response to Dexamethasone as Prognostic Factor: Result from Indonesian Childhood WK-ALL Protocol in Yogyakarta. J Oncol 2012 0.78
42 Does aid reach the poor? Experiences of a childhood leukaemia outreach-programme. Eur J Cancer 2008 0.78
43 Parental experiences of childhood leukemia treatment in indonesia. J Pediatr Hematol Oncol 2008 0.78
44 Survivors of childhood cancer. N Engl J Med 2007 0.75
45 Towards individualised treatment in childhood leukaemia. Lancet Oncol 2010 0.75
46 A medication diary-book for pediatric patients with acute lymphoblastic leukemia in Indonesia. Pediatr Blood Cancer 2013 0.75
47 Different outcome in older children with acute lymphoblastic leukemia with different treatment protocols in the Netherlands. Pediatr Blood Cancer 2011 0.75
48 L-asparaginase: long-term results of a randomized trial of the effect of additional 3 doses during consolidation treatment in the Indonesian WK-ALL-2000 protocol. J Pediatr Hematol Oncol 2013 0.75